Meralgia Paresthetica Market Research Report - Global Forecast till 2027

Meralgia Paresthetica Market Research Report: By Diagnosis (Imaging Techniques, Electromyography, Nerve Conduction Study, Nerve Blockade), Treatment (Medication, Surgery), End User (Hospitals & Clinics, Research Laboratories) - Global Forecast till 2027

ID: MRFR/MED/3870-HCR | | Region: Global | 105 pages

Please note that the assessment period of report has been updated from 2018-2025 to 2020-2027. Cordially fill the sample form for updated data

Market Scenario


Meralgia paresthetica is a condition characterized by tingling, numbness and burning pain in outer thigh. The major cause of meralgia paresthetica is compression of the nerve that supplies sensation to the skin surface of the thigh. The meralgia paresthetica market growth is majorly attributed to the increasing prevalence of obesity, rising funding, and healthcare insurance coverage. Moreover, common causes of this compression includes any condition that increases pressure on the groin such as tight clothing i.e. belts, corsets and tight pants, obesity or weight gain, wearing a heavy tool belt, pregnancy, scar tissue near the inguinal ligament due to injury or any previous surgery. Furthermore, nerve injury, which due to diabetes or seat belt injury after an accident (by motor vehicle), can also cause meralgia paresthetica.


As per the National Diabetes Statistics Report suggested by the Centers for Disease Control and Prevention, it is found that 9.4% of the U.S. population i.e. 30.3 million people had diabetes in 2015. The rising prevalence of diabetes in low and middle-income countries appears to be fuelled by nutrition transition, rapid urbanization, and increasingly sedentary lifestyles, suggested by a study published in the journal Pharmacoeconomics in 2015. Furthermore, globalization in healthcare has increased the market growth. Established market players in the developed countries leads the globalization by pushing new products and services into the developing countries and emerging economies. According to the World Health Organization estimates, head injuries are responsible for 4.5%-11% of all injuries in the world including low or high income economies. This is far higher as compared to the number of respiratory ailments, gastrointestinal disorders, or cancers, and the burden is expected to increase further over the coming years.


On the other hand, availability of expensive treatment may hamper the market growth during the forecast period.


The Global Meralgia Paresthetica Market is expected to grow at a CAGR of ~7.9 % during the forecast period 2017-2023.



Intended Audience



  • Medical Devices Companies

  • Research and Development (R&D) Companies

  • Government Research Institute

  • Academic Institutes and Universities


Figure: Global Meralgia Paresthetica Market, By Region Market Share, 2016 (%)
Meralgia Paresthetica Market

Sources: Annual reports, Press release, White paper, Company presentation


Segmentations


The Global Meralgia Paresthetica Market is segmented on the basis of types, by treatment, and by end user.


On the basis of diagnosis, it is segmented into imaging techniques, electromyography, nerve conduction study, nerve blockade. Imaging techniques are further segmented as X-ray radiography, magnetic resonance imaging, medical ultrasonography or ultrasound, and others.


Based on the treatment, it is segmented into medication, surgery, and others. Medication is further segmented into corticosteroid injections, tricyclic antidepressants, and anti-seizure. Anti-seizure is further segmented into gabapentin (gralise, neurontin), phenytoin (Dilantin) or pregabalin (lyrica) and others.


On the basis of end user, it is segmented into hospitals & clinics, research laboratories, and others.


Key Players


Some of key the players in the market are LivaNova PLC (U.K), EnteroMedics Inc. (U.S.), ElectroCore Medical LLC (U.S.), Boston Scientific Corporation (U.S.), Cyberonics, Inc. (U.S.), NeuroMetrix, Inc.(U.S.), ImThera Medical (U.S.), and Inspire Medical Systems, Inc.(U.S.) and others.


Research Methodology
Meralgia Paresthetica Market 2018
Sources: Annual reports, Press release, White paper, and Company presentation


Regional Analysis


The Americas dominate the global meralgia paresthetica market owing to well-developed technology, increasing patient with obesity, high healthcare spending, and increasing government support for research & development. Furthermore, increased R&D activities and the concentration of major companies have fuelled the growth of the market in this region.


Europe holds the second position in the global meralgia paresthetica market owing to the government support for research & development and availability of funds for research. Moreover, this is expected to continue to drive the European market over the forecasted period. For instance, countries like Germany and France are increasing investment in the healthcare domain.    


Asia Pacific is the fastest growing meralgia paresthetica market owing to the presence of rapidly developing healthcare technology, huge patient population, and high healthcare expenditure. Moreover, increasing demand for new treatment methods for chronic diseases in countries like India and South Korea is likely to emerge as the fastest growing market across the globe. Furthermore, increasing demand for quality devices in the healthcare is projected to lead to the use of advanced equipment, which, in turn, will increase the market growth of meralgia paresthetica in the region.   


On the other hand, in the Middle East and Africa, obesity and diabetes have become a huge problem due to limited screening, ignorance of diseases, and poor access to treatment.



Frequently Asked Questions (FAQ) :


meralgia paresthetica market is projected to grow at a 7.9% CAGR between 2017-2023.

The Americas is expected to dominate the meralgia paresthetica market.

Rising prevalence of obesity and globalization in healthcare are the key factors adding to the meralgia paresthetica market growth.

The availability of cost-effective treatment may limit the meralgia paresthetica market growth.

Key players profiled in the meralgia paresthetica market include Inspire Medical Systems, Inc. (U.S.), ImThera Medical (U.S.), NeuroMetrix, Inc. (U.S.), Cyberonics, Inc. (U.S.), Boston Scientific Corporation (U.S.), ElectroCore Medical LLC (U.S.), EnteroMedics Inc. (U.S.), and LivaNova PLC (U.K.).

Table Of Content

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

5.1.2 Bargaining Power Of Buyers

5.1.3 Threat Of New Entrants

5.1.4 Threat Of Substitutes

5.1.5 Intensity Of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Meralgia Paresthetica Market, By Diagnosis

6.1 Introduction

6.2 Imaging Techniques

6.2.1 Market Estimates & Forecast, 2020 – 2027

6.3 Electromyography

6.3.1 Market Estimates & Forecast, 2020 – 2027

Chapter 7. Global Meralgia Paresthetica Market, By Treatment

7.1 Introduction

7.2 Medication

7.2.1 Market Estimates & Forecast, 2020 – 2027

7.3 Surgery

7.3.1 Market Estimates & Forecast, 2020 – 2027

Chapter 8. Global Meralgia Paresthetica Market, By End User

8.1 Introduction

8.2 Hospitals & Clinics

8.2.1 Market Estimates & Forecast, 2020 – 2027

8.3 Research Laboratories

8.3.1 Market Estimates & Forecast, 2020 – 2027

8.4 Others

Chapter 9. Global Meralgia Paresthetica Market, By Region

9.1 Introduction

9.2 America

9.2.1 North America

9.2.1.1 US

9.2.1.1 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest Of Western Europe

9.3.2 Eastern Europe

9.4 Asia Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 Republic Of Korea

9.4.6 Rest Of Asia Pacific

9.5 The Middle East & Africa

9.5.1 United Arab Emirates

9.5.2 Saudi Arabia

9.5.3 Oman

9.5.4 Kuwait

9.5.5 Qatar

9.5.6 Rest Of The Middle East & Africa

Chapter 10 Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

10.3.1 Key Developments

Chapter 11 Company Profiles

11.1 Boston Scientific Corporation

11.1.1 Company Overview

11.1.2 Product Overview

11.1.3 Financials

11.1.4 SWOT Analysis

11.2 ElectroCore Medical LLC

11.2.1 Company Overview

11.2.2 Product Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 EnteroMedics Inc

11.3.1 Company Overview

11.3.2 Product Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 LivaNova PLC

11.4.1 Company Overview

11.4.2 Product /Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 Cyberonics, Inc.

11.5.1 Company Overview

11.5.2 Product Overview

11.5.3 Financial Overview

11.5.4 Key Developments

11.6 NeuroMetrix, Inc.

11.6.1 Company Overview

11.6.2 Product Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.7 Inspire Medical Systems, Inc.

11.7.1 Overview

11.7.2 Product Overview

11.7.3 Financials

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 Others

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s View Point

12.1.2 Unmet Needs Of The Market

12.2 Key Companies To Watch

12.3 Prediction Of Healthcare Industry

Chapter 13 Appendix


LIST OF TABLES

Table 1 Meralgia ParestheticaIndustry Synopsis, 2020 – 2027

Table 2 Global Meralgia Paresthetica Market Estimates And Forecast, 2020 – 2027, (USD Million)

Table 3 Global Meralgia Paresthetica Market By Region, 2020 – 2027, (USD Million)

Table 4 Global Meralgia Paresthetica Market By Diagnosis, 2020 – 2027, (USD Million)

Table 5 Global Meralgia Paresthetica Market By Treatment, 2020 – 2027, (USD Million)

Table 6 Global Meralgia Paresthetica Market By End Users, 2020 – 2027, (USD Million)

Table 7 North America Meralgia Paresthetica Market By Diagnosis, 2020 – 2027, (USD Million)

Table 8 North America Meralgia Paresthetica Market By Treatment, 2020 – 2027, (USD Million)

Table 9 North America Meralgia Paresthetica Market By End Users, 2020 – 2027, (USD Million)

Table 10 US Meralgia Paresthetica Market By Diagnosis, 2020 – 2027, (USD Million)

Table 11 US Meralgia Paresthetica Market By Treatment, 2020 – 2027, (USD Million)

Table 12 US Meralgia Paresthetica Market By End Users, 2020 – 2027, (USD Million)

Table 13 Canada Meralgia Paresthetica Market By Diagnosis, 2020 – 2027, (USD Million)

Table 14 Canada Meralgia Paresthetica Market By Treatment, 2020 – 2027, (USD Million)

Table 15 Canada Meralgia Paresthetica Market By End Users, 2020 – 2027, (USD Million)

Table 16 South America Meralgia Paresthetica Market By Diagnosis, 2020 – 2027, (USD Million)

Table 17 South America Meralgia Paresthetica Market By Treatment, 2020 – 2027, (USD Million)

Table 18 South America Meralgia Paresthetica Market By End Users, 2020 – 2027, (USD Million)

Table 19 Europe Meralgia Paresthetica Market By Diagnosis, 2020 – 2027, (USD Million)

Table 20 Europe Meralgia Paresthetica Market By Treatment, 2020 – 2027, (USD Million)

Table 21 Europe Meralgia Paresthetica Market By End Users, 2020 – 2027, (USD Million)

Table 22 Western Europe Meralgia Paresthetica Market By Diagnosis, 2020 – 2027, (USD Million)

Table 23 Western Europe Meralgia Paresthetica Market By Treatment, 2020 – 2027, (USD Million)

Table 24 Western Europe Meralgia Paresthetica Market By End Users, 2020 – 2027, (USD Million)

Table 25 Eastern Europe Meralgia Paresthetica Market By Diagnosis, 2020 – 2027, (USD Million)

Table 26 Eastern Europe Meralgia Paresthetica Market By Treatment, 2020 – 2027, (USD Million)

Table 27 Eastern Europe Meralgia Paresthetica Market By End Users, 2020 – 2027, (USD Million)

Table 28 Asia Pacific Meralgia Paresthetica Market By Diagnosis, 2020 – 2027, (USD Million)

Table 29 Asia Pacific Meralgia Paresthetica Market By Treatment, 2020 – 2027, (USD Million)

Table 30 Asia Pacific Meralgia Paresthetica Market By End Users, 2020 – 2027, (USD Million)

Table 31 Middle East & Africa Meralgia Paresthetica Market By Diagnosis, 2020 – 2027, (USD Million)

Table 32 The Middle East & Africa Meralgia Paresthetica Market By Treatment, 2020 – 2027, (USD Million)

Table 33 The Middle East & Africa Meralgia Paresthetica Market By End Users, 2020 – 2027, (USD Million)


LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation For Global Meralgia Paresthetica Market

Figure 3 Segmentation Market Dynamics For Global Meralgia Paresthetica Market

Figure 4 Global Meralgia Paresthetica Market Share, By Diagnosis 2020

Figure 5 Global Meralgia Paresthetica Market Share, By Treatment 2020

Figure 6 Global Meralgia Paresthetica Market Share, By End Users, 2020

Figure 7 Global Meralgia Paresthetica Market Share, By Region, 2020

Figure 8 North America Meralgia Paresthetica Market Share, By Country, 2020

Figure 9 Europe Meralgia Paresthetica Market Share, By Country, 2020

Figure 10 Asia Pacific Meralgia Paresthetica Market Share, By Country, 2020

Figure 11 Middle East & Africa Meralgia Paresthetica Market Share, By Country, 2020

Figure 12 Global Meralgia Paresthetica Market: Company Share Analysis, 2020 (%)

Figure 13 LivaNova PLC: Key Financials

Figure 14 LivaNova PLC: Segmental Revenue

Figure 15 LivaNova PLC: Geographical Revenue

Figure 16 EnteroMedics Inc: Key Financials

Figure 17 EnteroMedics Inc: Segmental Revenue

Figure 18 EnteroMedics Inc: Geographical Revenue

Figure 19 ElectroCore Medical LLC: Key Financials

Figure 20 ElectroCore Medical LLC: Segmental Revenue

Figure 21 ElectroCore Medical LLC: Geographical Revenue

Figure 22 Boston Scientific Corporation: Key Financials

Figure 23 Boston Scientific Corporation: Segmental Revenue

Figure 24 Boston Scientific Corporation: Geographical Revenue

Figure 25 Cyberonics, Inc.: Key Financials

Figure 26 Cyberonics, Inc: Segmental Revenue

Figure 27 Cyberonics, Inc: Geographical Revenue

Figure 28 NeuroMetrix, Inc..: Key Financials

Figure 29 NeuroMetrix, Inc.: Segmental Revenue

Figure 30 NeuroMetrix, Inc..: Geographical Revenue

Figure 31 Inspire Medical Systems, Inc.: Key Financials

Figure 32 Inspire Medical Systems, Inc.: Segmental Revenue

Figure 33 Inspire Medical Systems, Inc.: Geographical Revenue

Bottom of Form